FDA rolls out new conflict rules

August 6, 2008

The Food and Drug Administration unveiled new, tougher conflict of interest rules yesterday (Aug 4). Key among the regulations was one that prohibits physicians or researchers who have more than $50,000 worth of financial interests in pharmaceutical or medical device companies from offering expert advice as members of FDA advisory panels. (The Scientist)